JFitzgibbon

TL2 Member · Valladolid, ES

Keeps a personal log and shares the numbers when they are relevant, with the measurement caveats attached.

Joined 21 September 2025 · last posted 3d

87 posts, newest first. Showing up to 150.

I joined for one answer and stayed for a year — what changed my mind Replied, post #107 · Start Here › Welcome · 25 Jul 2026 · 8 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #129 · Evidence › Journal club · 23 Jul 2026 · 28 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
Documenting a supplier's response to a discrepancy Replied, post #43 · Sourcing › Vendor reports · 20 Jul 2026 · 23 likes post #42 answers the question as asked. The question underneath it is different. What "verified" means on our pages: specific lots were independently measured on stated…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #119 · Evidence › Journal club · 19 Jul 2026 · 12 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
Revisiting: How this community labels and discusses unrefereed work Replied, post #27 · Evidence › Preprints · 17 Jul 2026 · 29 likes Coming back to post #25, because the follow-up matters more than the original answer. Unrefereed work is not worthless. A great deal of it survives review substantially…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #64 · Practice › Dosing & titration · 14 Jul 2026 · 0 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
Reading order for a first week here, and what to skip until later — what changed since Replied, post #36 · Start Here › Welcome · 12 Jul 2026 · 32 likes Coming back to post #34, because the follow-up matters more than the original answer. Nothing here requires expertise. The experienced members here got that way by…
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #83 · Practice › Interactions · 11 Jul 2026 · 11 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #15 · Clinical › Comorbidities · 10 Jul 2026 · 0 likes Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes; SUSTAIN 6 was in high-risk diabetes. Absolute…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #7 · Access › Insurance & coverage · 7 Jul 2026 · 4 likes This follows post #4 rather than contradicting it. Documentation your clinician can provide: letters from clinicians describing why standard treatments have failed or…
I joined for one answer and stayed for a year — what changed my mind Replied, post #41 · Start Here › Welcome · 25 Jun 2026 · 0 likes post #40 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
Preservatives: function, testing, and limits — one year on Replied, post #26 · Pharmacology › Formulation chemistry · 23 Jun 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #99 · Evidence › Journal club · 22 Jun 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Injecting into an area that has become firm: why not to Replied, post #56 · Practice › Administration · 12 Jun 2026 · 7 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
Asking a follow-up: new topic or new reply? Replied, post #7 · Start Here › How to Ask · 11 Jun 2026 · 7 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #58 · Safety › Contraindications · 1 Jun 2026 · 0 likes Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying. Pre-existing severe gastroparesis can be worsened. That is a relative…
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #36 · Compounds › Semaglutide · 23 May 2026 · 0 likes post #35 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
Prescription requirements and telehealth models — a second dataset Replied, post #32 · Sourcing › Regulatory · 17 May 2026 · 0 likes Picking up post #29: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
Why fasting instructions for oral semaglutide are not optional advice Replied, post #4 · Compounds › Oral incretins · 15 May 2026 · 5 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #115 · Devices › Syringes & needles · 13 May 2026 · 32 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Revisiting: Absolute versus relative contraindications Replied, post #84 · Safety › Contraindications · 7 May 2026 · 30 likes This follows post #81 rather than contradicting it. Concurrent insulin or sulfonylureas: not an absolute contraindication but requires dose adjustment and close…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #80 · Clinical › Bloodwork · 13 Apr 2026 · 6 likes Worth separating two things that post #76 runs together. Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more…
Bug report: the reconstitution calculator and a rounding edge case Replied, post #50 · Data & Tools › Calculators · 8 Apr 2026 · 12 likes The calculators maintained on this site are open-source and verifiable. They are intended to check arithmetic, not to replace medical judgement. Using them is optional…
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold? Replied, post #13 · Data & Tools › Datasets · 8 Apr 2026 · 0 likes Privacy: if contributing data, only share data you are comfortable making permanent and public. Once posted, data is persistent.
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #102 · Clinical › Bloodwork · 16 Mar 2026 · 11 likes Picking up post #99: that is the part I would want checked first. Biological variation: the person-to-person variation in a biomarker for a healthy person is larger…
Shoulders, tangent skims, and defensible integration — the long version Replied, post #16 · Analytics › HPLC & UHPLC · 13 Mar 2026 · 9 likes On post #12 — agreed on the reasoning, with one qualification. System suitability testing: injections run before and during the sample run to establish whether the…
Grapefruit: why this class is not the class that cares Replied, post #35 · Practice › Interactions · 13 Mar 2026 · 26 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Reading U-100 graduations, with a conversion table — one year on Replied, post #6 · Devices › Syringes & needles · 12 Mar 2026 · 7 likes Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous injection, 27-30G is typical. Finer needles take…
Publication bias detection and its low power — does this still hold? Replied, post #16 · Evidence › Meta-analyses · 8 Mar 2026 · 0 likes I read post #14 twice before replying, because I had assumed the opposite. Pooled estimates and heterogeneity: when trials differ in population, duration, or…
Choosing which test to pay for, given a fixed budget Replied, post #14 · Sourcing › Independent verification · 5 Mar 2026 · 2 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #131 · Compounds › Semaglutide · 28 Feb 2026 · 32 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
Stepping down deliberately, and how to do it without losing progress Replied, post #59 · Practice › Dosing & titration · 16 Feb 2026 · 31 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
Second pass at: The topic list is dense — is that deliberate? Replied, post #52 · Meta › Site feedback · 24 Jan 2026 · 0 likes Guideline clarity: if the guidelines are unclear or seem to be applied inconsistently, post the specific situation so staff can clarify or reconsider.
Why the titration planner refuses to produce a schedule below a floor Replied, post #29 · Data & Tools › Calculators · 17 Jan 2026 · 0 likes post #28 answers the question as asked. The question underneath it is different. Reporting bugs: if you notice a calculator giving wrong results, report it in this…
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #28 · Start Here › Welcome · 6 Jan 2026 · 0 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #122 · Compounds › Oral incretins · 1 Jan 2026 · 25 likes I read post #120 twice before replying, because I had assumed the opposite. Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #94 · Analytics › COA interpretation · 21 Dec 2025 · 26 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Comparing my trajectory with the trial curves, carefully Replied, post #89 · Outcomes › Progress reports · 12 Dec 2025 · 2 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
Tracking a preprint to publication: a worked example Replied, post #121 · Evidence › Preprints · 12 Dec 2025 · 13 likes This follows post #118 rather than contradicting it. What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #113 · Practice › Reconstitution · 5 Dec 2025 · 20 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
What a purity-only report leaves out Replied, post #99 · Sourcing › Independent verification · 23 Nov 2025 · 16 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
Sleep tracking data and its considerable limitations Replied, post #99 · Wellbeing › Sleep · 27 Oct 2025 · 3 likes Gastrointestinal effects overnight: nausea or reflux or constipation at night can disrupt sleep. Dosing timing (morning versus evening) might help if nighttime GI…
Reconciling a supplier certificate with an independent result Replied, post #15 · Sourcing › Vendor reports · 26 Oct 2025 · 25 likes Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current…
A parcel that arrived warm: a decision process, not a verdict Replied, post #102 · Practice › Storage & stability · 25 Oct 2025 · 3 likes On post #98 — agreed on the reasoning, with one qualification. Published stability data applies specifically to the formulation studied, under the specific conditions…
Power cut for eleven hours: how I assessed it afterwards Replied, post #109 · Practice › Storage & stability · 24 Oct 2025 · 0 likes Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure is worth avoiding. The concentration matters…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #37 · Compounds › Tirzepatide · 20 Oct 2025 · 1 like Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
Reconciling a supplier certificate with an independent result Replied, post #10 · Sourcing › Vendor reports · 20 Oct 2025 · 11 likes This follows post #7 rather than contradicting it. Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do…
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #57 · Start Here › Welcome · 17 Oct 2025 · 16 likes post #56 is right about the mechanism and I think understates the practical bit. Trust levels accumulate over time and they give you access to small things like the…
MHRA statements, read directly Replied, post #5 · Regional › UK & Ireland · 19 Sep 2025 · 18 likes MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria…
Payment method and the leverage it gives you, ranked Replied, post #22 · Sourcing › Payments · 16 Sep 2025 · 0 likes No payment facilitation: this site does not handle payments and does not connect buyers and sellers for the purpose of payment. We discuss logistics and documentation…
Realistic expectations for strength while losing weight quickly Replied, post #18 · Nutrition & Training › Resistance training · 3 Sep 2025 · 0 likes Post-weight-loss training: once weight loss is complete and energy deficit ends, training can shift to building again. The transition from preservation mode to building…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #52 · Practice › Reconstitution · 1 Sep 2025 · 17 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #43 · Practice › Side effects · 20 Aug 2025 · 9 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #83 · Compounds › Oral incretins · 16 Aug 2025 · 1 like PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #37 · Compounds › Retatrutide · 6 Aug 2025 · 0 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #8 · Compounds › Secretagogues & GH axis · 23 Jul 2025 · 4 likes post #7 is right about the mechanism and I think understates the practical bit. GHRH analogues versus ghrelin mimetics are often conflated but they are different…
A field-by-field walk through a certificate of analysis Replied, post #139 · Analytics › COA interpretation · 18 Jul 2025 · 0 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
Preparing for an appointment: one page, three questions Replied, post #27 · Clinical › Prescriber conversations · 14 Jul 2025 · 0 likes Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #32 · Compounds › Cagrilintide & amylin analogues · 9 Jul 2025 · 0 likes post #31 is right about the mechanism and I think understates the practical bit. What is genuinely unknown about long-term amylin agonism: real-world response rates,…
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #56 · Evidence › Journal club · 27 Jun 2025 · 7 likes Coming back to post #54, because the follow-up matters more than the original answer. Session format: read the paper before posting. The discussion is much better when…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #11 · Documentation › Doc review · 10 Jun 2025 · 4 likes Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it here. The goal is accuracy and clarity, not authorship.
A certificate whose chromatogram axes do not match its stated method Replied, post #13 · Sourcing › Red flags · 10 Jun 2025 · 0 likes On post #9 — agreed on the reasoning, with one qualification. Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because…
An emergency department visit, described afterwards Replied, post #27 · Safety › Adverse events · 3 Jun 2025 · 9 likes Serious and unexpected events are the ones to document and report. Serious means hospitalization-level serious. Unexpected means not in the drug's known profile. Both…
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #4 · Evidence › Trials · 29 May 2025 · 3 likes I read post #2 twice before replying, because I had assumed the opposite. Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a…
Albumin binding and how it produces a long half-life Replied, post #36 · Pharmacology › Pharmacokinetics · 14 May 2025 · 11 likes Worth separating two things that post #32 runs together. Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is…
Antibiotics and a course of something with delayed emptying Replied, post #41 · Practice › Interactions · 14 May 2025 · 7 likes Worth separating two things that post #37 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
A well-designed study with a badly written abstract Replied, post #64 · Evidence › Study critique · 6 May 2025 · 2 likes What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample…
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #28 · Compounds › Retatrutide · 24 Apr 2025 · 21 likes post #27 answers the question as asked. The question underneath it is different. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple…
Second pass at: A history of disordered eating: proceeding carefully Replied, post #20 · Wellbeing › Mental health · 18 Mar 2025 · 22 likes Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters for risk. Someone with a history of depression should plan…
Requesting a page: what makes a good request Replied, post #27 · Documentation › Wiki requests · 18 Mar 2025 · 1 like Request a new maintained page: if a question recurs, has a good marked solution, and contains a worked example, it is a candidate for promotion to a maintained…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #23 · Compounds › Tirzepatide · 9 Mar 2025 · 1 like SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #2 · marked as the solution · Evidence › Journal club · 19 Feb 2025 · 15 likes Coming back to the opening post, because the follow-up matters more than the original answer. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be…
When a preprint is the best available evidence and we say so — a second dataset Replied, post #12 · Evidence › Preprints · 30 Jan 2025 · 1 like Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
Oxidation and deamidation mass shifts, tabulated Replied, post #40 · Analytics › Mass spectrometry · 21 Jan 2025 · 4 likes post #39 answers the question as asked. The question underneath it is different. Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at…
What we do not know about retatrutide, listed explicitly Replied, post #61 · Compounds › Retatrutide · 19 Jan 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #6 · Compounds › Repair & healing peptides · 14 Jan 2025 · 17 likes Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from one research group. That is not necessarily wrong — one group can do…
[2026 update] New subcategory: rationale and scope Replied, post #134 · Meta › Announcements · 9 Jan 2025 · 22 likes post #133 answers the question as asked. The question underneath it is different. Scheduled maintenance: if the site is going offline for maintenance, advance notice…
HbA1c lag and what it can and cannot tell you at eight weeks Started this topic · Clinical › Bloodwork · 22 Dec 2024 · 0 likes HbA1c lag and what it can and cannot tell you at eight weeks Writing it up because I had to work it out twice and would rather nobody else did. General question, not a…
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #20 · Practice › Reconstitution · 20 Nov 2024 · 0 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #68 · Analytics › Method validation · 8 Nov 2024 · 14 likes This follows post #65 rather than contradicting it. Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by…
Transporting a vial for a weekend away Replied, post #26 · Practice › Storage & stability · 2 Nov 2024 · 1 like On post #22 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
Relative retention time as a better inter-laboratory comparator — does this still hold? Replied, post #15 · Analytics › Method validation · 22 Oct 2024 · 9 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
Why I ask for the gradient before I discuss the number Replied, post #12 · Analytics › HPLC & UHPLC · 9 Aug 2024 · 28 likes Coming back to post #10, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
Guidelines revision: what changed and why Replied, post #128 · Meta › Announcements · 28 Jul 2024 · 8 likes Worth separating two things that post #124 runs together. Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here with…
The mass-error checker and its intended scope Replied, post #155 · Data & Tools › Calculators · 26 Jul 2024 · 3 likes I read post #153 twice before replying, because I had assumed the opposite. Units: all calculators explicitly require units to be stated. This prevents the…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #107 · Compounds › Retatrutide · 23 Jul 2024 · 3 likes post #106 is right about the mechanism and I think understates the practical bit. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison…
Spreadsheets: an appreciation Replied, post #25 · Lounge › Off topic · 9 Jun 2024 · 2 likes Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that.